上海什么是室壁瘤上海乳腺结节吃什么药能好能消掉结节,上海肾结晶严重吗,上海两肺多发斑片,结节及条索影,边界模糊,,上海哪里可以做病理检测,上海心肺毛病可否用针炙的头针治疗,上海肾结晶最快的排出方法,上海开甲状腺结节后有什么后遗症

SAN FRANCISCO, June 13 (Xinhua) -- Social networking giant Facebook will likely go public in the first quarter of 2012 with a valuation that could top 100 billion U.S. dollars, U.S. media reported on Monday.In a report, CNBC quoted people familiar with the matter as saying that Facebook could submit filing to register its securities with the U.S. Securities and Exchange Commission (SEC) as early as October or November this year.People who are on Wall Street and track this information told the business news television channel that they think the Facebook initial public offering (IPO), if and when it happens could value the company of more than 100 billion dollars.A factor in the company's IPO timing is the SEC's requirement that companies must disclose financial information if they have more than 500 private investors."The company has until the end of April 2012 to disclose their financials, but they may just want to get ahead of that by doing a formal initial public offering, I'm told. And that could happen in the first quarter of the year," said CNBC Wall Street reporter Kate Kelly.Facebook is also facing internal pressure as employees have not been permitted to sell their private shares on the secondary market since last spring. An IPO would make it easier for employees to monetize their shares, said Kelly, citing sources.Facebook shares have been traded in private markets such as Sharepost.com, which puts the social networking company's valuation at 85 billion dollars.Meanwhile, latest data show that Facebook is losing users last month in the United States, Canada and several European countries, indicating that the company could have hit the limits of expansion in its mature markets.

BEIJING, June 27 (Xinhuanet) -- A "lean gene" that helps people keep slim was found closely related to diabetes and heart disease, according to a study pulished in Nature Genetics journal on Sunday.The scientists from Britain’s Medical Research Council Epidemiology Unit conducted the study.After comparing the genetic codes of more than 75,000 people, a gene called IRS1 was spotted as the decisive factor to lower the fat level in human body.But in further study, IRS1 was found putting people to a 20 percent higher risk of developing heart disease and type-2 diabetes.The study warned that people who appear slim and fit might be also at risk.But scientists suggest that the study results did not change the general message for most people."While this study pointed to genes as one factor in determining the risk of developing these conditions, it was important to remember that lifestyle factors like diet, exercise, cutting out smoking and maintaining a healthy weight also play a vital role in reducing the risk," said Ruth Loos, who led the study.

WASHINGTON, Aug. 10 (Xinhua) -- After a journey of almost three years, NASA's Mars rover Opportunity has reached the Red Planet's Endeavour crater to study rocks never seen before, the U.S. National Aeronautics and Space Administration (NASA) announced on Wednesday.Scientists hope it will find rocks and terrain much older than any other that the itinerant robot has examined during its seven years on the red planet.The U.S. space agency said that Opportunity arrived at the rim of Endeavour on Tuesday. The golf cart-size rover is expected to remain at the 22-kilometer-wide crater for the next few years.A portion of the west rim of Endeavour crater sweeps southward in this color view from NASA's Mars Exploration Rover Opportunity."NASA is continuing to write remarkable chapters in our nation' s story of exploration with discoveries on Mars and trips to an array of challenging new destinations," NASA Administrator Charles Bolden said in a statement. "Opportunity's findings and data ... will play a key role in making possible future human missions to Mars and other places where humans have not yet been."NASA's Mars Reconnaissance Orbiter, which has been circling the planet since late 2005, detected clay minerals that form in wet conditions in the crater. Scientists want to find out if the minerals date back to Mars' distant past, when the planet is believed to have been wetter and warmer than the dry frozen desert it is today."We're soon going to get the opportunity to sample a rock type the rovers haven't seen yet," said Matthew Golombek, Mars Exploration Rover science team member, at NASA's Jet Propulsion Laboratory in Pasadena, Calif. "Clay minerals form in wet conditions so we may learn about a potentially habitable environment that appears to have been very different from those responsible for the rocks comprising the plains."NASA is searching for signs that Mars had a habitable environment billions of years ago. Knowledge of the Martian climate will be important to future manned missions there, and can shed light on the forces that shaped Earth's climate.NASA launched the Mars rovers Opportunity and Spirit in 2003 for what were planned to be three-month missions. But both continued operating well beyond that. Spirit stopped communicating in March 2010.

WASHINGTON, Sept. 14 (Xinhua) -- Controlling diabetes may someday involve mining stem cells from the lining of the uterus, Yale School of Medicine researchers report in a new study published Wednesday in the journal Molecular Therapy. The team treated diabetes in mice by converting cells from the uterine lining into insulin-producing cells.The endometrium or uterine lining, is a source of adult stem cells. These cells generate uterine tissue each month as part of the menstrual cycle. Like other stem cells, however, they can divide to form other kinds of cells.Led by Yale Professor Hugh Taylor, the researchers bathed endometrial stem cells in cultures containing special nutrients and growth factors. Responding to these substances, the endometrial stem cells adopted the characteristics of beta cells in the pancreas that produce insulin. Over the course of a three- week incubation process, the endometrial stem cells took on the shape of beta cells and began to make proteins typically made by beta cells. Some of these cells also produced insulin.After a meal, the body breaks food down into components like the sugar glucose, which then circulates in the blood. In response, beta cells release insulin, which allows the body's cells to take in the circulating glucose. In this study, Taylor and his team exposed the mature stem cells to glucose and found that, like typical beta cells, the cultured cells responded by producing insulin. The team then injected diabetic mice with the mature, insulin-making stem cells. The mice had few working beta cells and very high levels of blood glucose.Mice that did not receive the stem cell therapy continued having high blood sugar levels, developed cataracts and were lethargic. In contrast, mice that received the cell therapy were active and did not develop cataracts, but the animals' blood sugar levels remained higher than normal.The Yale team's findings suggest that endometrial stem cells could be used to develop insulin-producing islet cells, which are found in the pancreas. These islet cells could then be used to advance the study of islet cell transplantation to treat people with diabetes.Taylor said in a statement that the next step in the research will be to verify how long this treatment remains effective.